#United States #orthodontics #San Clemente #Angelalign #Align Technology

In a landscape where legal battles often overshadow innovation, Angelalign Technology Inc., traded under the stock number 6699.HK, continues to assert its prominence amidst the latest complaints filed by industry giant Align Technology Inc. The most recent case involves the U.S. International Trade Commission, adding to a series of lawsuits that Align has hurled at competitors in the clear aligner market. Despite this adversity, Angelalign has responded with optimism and determination. Rich Hirschland, Chief Commercial Officer and Senior Vice President of Angelalign, expressed unwavering faith in the company's position. He noted, "This new lawsuit only underscores our commitment to providing innovative solutions to our clients and patients in 60 countries. We have been honored to receive overwhelming support from orthodontic professionals who have reached out to convey their appreciation for our products." This sentiment reflects a growing recognition of Angelalign's impact in an industry often marred by accusations of monopolistic practices and legal skirmishes. As the company prepares its defense, it is essential to acknowledge Angelalign's impressive innovation track record over its 20 years of operation. In this time, it has built a commendable reputation for respecting intellectual property rights while consistently pioneering new technologies in orthodontics. Several of the innovative products that highlight Angelalign's capabilities include the award-winning angelButton™ and angelHook™, which empower orthodontists to effectively manage forces when utilizing elastics. Moreover, their A6 mandibular advancement system showcases the application of the twin-block orthodontic concept, enabling better mandibular positioning. The AngelKid system is specifically designed to treat mixed dentition, making it a popular choice for pediatric patients. Additionally, the Intelligent Root System gives orthodontists the ability to leverage 3D imaging for comprehensive treatment planning, further placing Angelalign at the forefront of orthodontic technology. "While competitor’s diversions might seem distracting, our top priority remains steadfast—serving our customers and treating our employees with the utmost respect," said Jason Tabb, Angelalign's General Manager and Vice President of North America. This assertiveness demonstrates Angelalign’s commitment to its foundational values, indicating that despite the ongoing legal tussles, the company is not deterred from focusing on its key goals. Celebrating 1.5 million smiles, Angelalign is dedicated to enriching the orthodontic experience for both practitioners and patients. Their presence in the market is rapidly growing, as evidenced by unexpected waves of business acceleration in North America following the initiation of the lawsuits. Moreover, with Angelalign's successful debut on the Hong Kong Stock Exchange in 2021, garnering a market capitalization near $1 billion, it is clear that the company is navigating the waters of competition with solid strategies and innovative products. As it continues to thrive, the endorsement from leading industry professionals stands as a testament to the tangible benefits that Angelalign's technologies provide. As the legal proceedings unfold, many will be watching closely to see how Angelalign leverages its innovative solutions to maintain its competitive edge in the orthodontics sector. It is clear that while the business landscape may be fraught with challenges, Angelalign Technologies is poised to rise above them by remaining true to its core mission: delivering effective, patient-centered solutions in orthodontic care.